Abstract
BackgroundLiqi, an herbal preparation used in traditional Chinese medicine, has been used to treat cancer in China for centuries. We investigated the anti-tumor effects of liqi and their mechanisms in mice that had been xenografted with tumors.MethodsSarcoma 180 tumor, Lewis lung carcinoma, and SGC-7901 cells were implanted in BALB/c mice, C57BL/6 mice, and BALB/c nude mice, respectively. Liqi was administered to subgroups of these mice. The tumor weight and size were measured. Cell cycle analysis and T lymphocyte subsets were determined by flow cytometry. The activity of NK cells and TNF was tested using cytotoxicity assay on YAC-1 cells and L929 cells, respectively, and the activity of IL-2 was tested with an IL-2-dependent CTLL-2 cell proliferation assay. Platelet aggregation was monitored by measuring electric impedance, and the levels of thromboxane A2 (TXA2) and prostacyclin (PGI2) in blood were measured by 125I-TXB2 and 125I-Keto-PGF1α radioimmunoassay.ResultsThe results showed that liqi inhibited tumor growth in tumor-implanted mice and arrested the cell proliferation in the G0/G1 phase and reduced the portion of cells in S and G2/M phase for SGC-7901 cells. Liqi increased the activity of NK cells and TNF-α, stimulated IL-2 production and activity, and regulated T lymphocyte subpopulations. Liqi inhibited the Lewis lung carcinoma metastasis by inhibiting platelet aggregation and normalizing the balance between TXA2 and PGI2.ConclusionAll these findings demonstrated that liqi has an anti-tumor effect in vivo. The mechanism may be related to immune regulation and anticoagulation effects.
Highlights
Liqi, an herbal preparation used in traditional Chinese medicine, has been used to treat cancer in China for centuries
A traditional Chinese medicine made from Poncirus trifoliate (L.)Raf, Akebia Trifoliate Koidz, Citrus medica var. sarcodactylis Swingle and Saussurea lappa, has been used to treat malignancies in traditional Chinese medicine for centuries
Effect of liqi on tumor growth in the tumor-transplanted mice To explore the role of liqi on tumor growth in mouse Sarcoma 180 transplanted into BALB/c mice and Lewis lung carcinoma transplanted into C57BL/6 mice, we treated tumor-bearing mice with various doses of liqi (12.5, 25, 50 g/kg)
Summary
An herbal preparation used in traditional Chinese medicine, has been used to treat cancer in China for centuries. In the search for new cancer therapeutics with low toxicity and few side effects, traditional Chinese medicines are promising candidates. A traditional Chinese medicine made from Poncirus trifoliate (L.)Raf, Akebia Trifoliate Koidz, Citrus medica var. Sarcodactylis Swingle and Saussurea lappa, has been used to treat malignancies in traditional Chinese medicine for centuries. The main active constituents are coumarins, flavonoids, and terpenoids in Poncirus trifoliate (L.)Raf; triterpene and triterpenoid saponin in Akebia Trifoliate Koidz; terpene, flavonoids and polysaccharide in Citrus medica var. Akebia Trifoliate Koidz inhibits the growth of breast cancer cell lines MDA-MB-231 and BT-483[8]. Saussurea lappa induces G2-growth arrest and apoptosis in AGS gastric cancer cells [9]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have